LY3209590
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for LY3209590, covering 2017-11-07 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus [Phase 1]